Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-15-012313
Filing Date
2015-06-15
Accepted
2015-06-15 16:18:28
Documents
1
Period of Report
2015-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rdgdoc.html 4/A  
1 FORM 4/A rdgdoc.xml 4/A 4055
  Complete submission text file 0001437749-15-012313.txt   5692
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5964 LA PLACE COURT CARLSBAD CA 92008
Business Address
Fox James (Reporting) CIK: 0001500591 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35285 | Film No.: 15931417